At present, there is no consensus on the pathogenesis of ALK inhibitor‐related arrhythmia, and plausible mechanisms that involve ion signaling pathways, endocrine regulation, and drug metabolism may underlie this condition. The gene discussed is ALK; the disease is cardiac arrhythmia.